What the trials established (STEP) Semaglutide's weight-management evidence comes chiefly from the STEP program ( The New England Journal of Medicine , 2021)
In a cohort of patients with metastatic melanoma, median survival was 26.67 months in 167 patients who did not receive a vaccine, but it had not yet been reached in 43 patients receiving a vaccine suggesting a significant improvement
Incidence rates, defined as the number of events divided by the follow-up time, were reported per 1000 person-years (PY) for CV outcomes
Gouri, A., Dekaken, A., Chefrour, M
In addition to systemic adverse effects, inhibiting BCL-2 family members could be problematic for diseases and conditions of the CNS